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Objectives.  
Bipolar disorder (BD) is highly heritable, and gene identification will elucidate 
biological factors and gene-environment interactions. Multiplex families represent a 
promising resource for identifying rare variants and polygenic effects. However, such 
families are difficult to recruit. 
In 1997, >100 multiplex Andalusian BD pedigrees - the largest of which contains >20 
affected members- were recruited within an Andalusian-German collaboration study.  
Since then, the Andalusian psychiatric network and biobank facilities have been 
expanded in order to facilitate psychiatric research. Therefore in 2013, the Andalusian-
German collaborators initiated a follow-up study of this cohort in order to identify new 
genetic and environmental factors for BD aetiology and clinical course.  
 
Methods. 
In 1997, BD patients at Andalusian psychiatric hospitals who reported a family history 
of BD were asked to inform their families about the study. All consenting family 
members (N= 937; BPI/II=265; Recurrent Mayor Depression=149) were assessed using 
a structured psychiatric interview for life-time best estimate psychiatric diagnosis 
(SADS) and the family history method, and blood was obtained for DNA genetic 
analysis. 
Follow-up involves reassessment of diagnosis, neuropsychological testing (CANTAB), 
and the collection of biomaterials (RNA, Plasma, IPS, hair cortisol, etc.). Written 
informed consent is obtained for all study procedures and analyses. 
  
Results.  
For the first three families, follow-up assessments and biomaterial-processing have been 
completed. Follow-up of the remaining families is ongoing.   
 
Conclusion. 
This cohort represents a unique resource for the investigation of BD aetiology and 
clinical course, and will be available to international researchers from other sciences.  
 
 
 
 
